Stock BTTX BETTER THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Market Closed - OTC Markets
Other stock markets
 03:50:49 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.009 USD +15.68% Intraday chart for Better Therapeutics, Inc. +12.50% -95.38%
Mar. 21 Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc CI
Mar. 20 Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index CI

Evolution of the average Target Price on Better Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ab7aef389d706ee0e454.k9yxT44cAfIlqiqi8v9qi9CiTlF_MLM369sd0Q_glXc.2eXZdtwtT6tBmmfztok81KHFNydKfOtipJEunEe09BnVsPANy2hLp2PdSQ~e731de97208726e31445b52295a59e61

Analyst Recommendations on Better Therapeutics, Inc.

Lake Street Adjusts Better Therapeutics' Price Target to $5 From $6, Keeps Buy Rating MT
Chardan Lowers Price Target on Better Therapeutics to $9 From $14, Reflecting Higher Projected Sharecount Dilution, Maintains Buy Rating MT
Chardan Cuts Price Target on Better Therapeutics to $14 From $17 on Higher Expected Share Count Dilution, Reiterates Buy Rating MT
Chardan Adjusts Better Therapeutics' Price Target to $17 From $15, Keeps Buy Rating MT
Chardan Raises Price Target on Better Therapeutics to $18 From $17, Maintains Buy Rating MT
LifeSci Capital Starts Better Therapeutics at Outperform With $15 Price Target MT
Chardan Starts Better Therapeutics at Buy With $17 Price Target MT
Cowen Initiates Coverage on Better Therapeutics With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.009 USD
Average target price
1.5 USD
Spread / Average Target
+16,566.67%
High Price Target
1.5 USD
Spread / Highest target
+16,566.67%
Low Price Target
1.5 USD
Spread / Lowest Target
+16,566.67%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Better Therapeutics, Inc.

Lake Street
Chardan Research
LifeSci Capital
Chardan
Cowen

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTTX Stock
  4. Consensus Better Therapeutics, Inc.